1. Home
  2. PKE vs IRWD Comparison

PKE vs IRWD Comparison

Compare PKE & IRWD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Park Aerospace Corp.

PKE

Park Aerospace Corp.

HOLD

Current Price

$26.85

Market Cap

680.4M

Sector

Industrials

ML Signal

HOLD

Logo Ironwood Pharmaceuticals Inc.

IRWD

Ironwood Pharmaceuticals Inc.

SELL

Current Price

$3.63

Market Cap

687.4M

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
PKE
IRWD
Founded
1954
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Military/Government/Technical
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
680.4M
687.4M
IPO Year
1994
2009

Fundamental Metrics

Financial Performance
Metric
PKE
IRWD
Price
$26.85
$3.63
Analyst Decision
Buy
Buy
Analyst Count
2
4
Target Price
★ $42.50
$6.10
AVG Volume (30 Days)
293.9K
★ 2.1M
Earning Date
10-08-2026
11-09-2026
Dividend Yield
★ 1.90%
N/A
EPS Growth
93.10
★ 1400.00
EPS
0.37
★ 0.55
Revenue
N/A
★ $298,276,000.00
Revenue This Year
$16.24
$59.19
Revenue Next Year
$17.78
$4.80
P/E Ratio
$71.00
★ $6.85
Revenue Growth
N/A
★ 8.88
52 Week Low
$18.25
$1.44
52 Week High
$39.86
$5.78

Technical Indicators

Market Signals
Indicator
PKE
IRWD
Relative Strength Index (RSI) 33.20 39.40
Support Level $25.70 $3.04
Resistance Level $29.36 $3.96
Average True Range (ATR) 1.17 0.18
MACD -0.21 -0.02
Stochastic Oscillator 24.33 15.14

Price Performance

Historical Comparison
PKE
IRWD

About PKE Park Aerospace Corp.

Park Aerospace Corp is an aerospace company that develops and manufactures composite materials used to produce composite structures for the aerospace market. Its products include film adhesives, lightning strike protection materials, specialty ablative materials for rocket motors and nozzles, and materials for radome applications. The Company offers composite materials designed for hand lay-up and automated fiber placement (AFP) manufacturing applications, which are used in jet engines, large and regional transport aircraft, military aircraft, unmanned aerial vehicles (UAVs), business jets, general aviation aircraft, and rotary wing aircraft. It operates in North America, Asia, and Europe, with North America generating maximum revenue.

About IRWD Ironwood Pharmaceuticals Inc.

Ironwood Pharmaceuticals Inc is a biotechnology company developing and commercializing life-changing therapies for people living with gastrointestinal, or GI, and rare diseases. It is focused on the development and commercialization of inventive product opportunities in areas of unmet need, leveraging its demonstrated expertise and capabilities in GI and rare diseases. LINZESS is its commercial product. LINZESS is also available for the treatment of adults with IBS-C or CIC in Mexico, adults with IBS-C or chronic constipation in Japan, and adults with IBS-C in China. Linaclotide is available under the trademarked name CONSTELLA for the treatment of adults with IBS-C or CIC and pediatric patients ages 6-17 years old with FC in Canada, and to adults with IBS-C in certain European countries.

Share on Social Networks: